This inventor holds 1 USPTO granted patent. Top assignee: Step Pharma S.a.s.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Emma Blackham: Innovator in Pharmaceutical Chemistry
Introduction
Emma Blackham is a notable inventor in the field of pharmaceutical chemistry. She has made significant contributions to the development of compounds that target human diseases. Her innovative work focuses on creating effective treatments for proliferative diseases.
Latest Patents
Emma holds a patent for her invention titled "N-(5-(6-ethoxypyrazin-2-yl)pyridin-2-yl)-4-(2-(methylsulfonamido)pyrimidin-4-yl) tetrahydro-2H-pyran-4-carboxamide derivatives and related compounds as human CTPS1 inhibitors for the treatment of proliferative diseases." This patent highlights her expertise in designing novel therapeutic agents.
Career Highlights
Emma is currently associated with Step Pharma S.a.s., where she continues to advance her research and development efforts. Her work has garnered attention for its potential impact on treating various health conditions.
Collaborations
Emma collaborates with talented professionals in her field, including Lorna Duffy and Pascal George. These partnerships enhance her research and contribute to the innovative environment at Step Pharma.
Conclusion
Emma Blackham is a pioneering inventor whose work in pharmaceutical chemistry is paving the way for new treatments. Her dedication to innovation and collaboration is making a significant difference in the fight against proliferative diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile